Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
Mark Moore

Eli Lilly To Invest $3B To Expand Plant To Meet Surge In Demand For Weight Loss Drugs

Eli Lilly announced a $3 billion expansion at a facility it bought in Wisconsin to accelerate production of its weight-loss drugs. (Credit: Scott Olson/Getty Images)

Eli Lilly announced a $3 billion expansion of a manufacturing facility the drugmaker bought earlier this year in Wisconsin to ramp up production of its diabetes and weight-loss drugs.

The pharmaceutical giant said it will expand the plant in Kenosha County, Wis., adding 750 jobs to the current 100-person workforce, to meet growing demand for its popular injectable drugs, Mounjaro and Zepbound.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.